Protein C News and Research

RSS

Eisai presents new research evaluating correlation of Abeta in plasma and CSF with automated protein assay system

Eisai Co.,Ltd. announced its latest research on evaluation about correlation of amyloid beta (Abeta) in plasma and in cerebrospinal fluid (CSF) by high precision measurement with the newly developed automated protein assay system, jointly developed with Sysmex Corporation, using full automated immunoassay system HISCLTM series for creating the simplified diagnosis of Alzheimer's disease with blood was presented at the Alzheimer's Association International Conference held in Los Angeles, California, United States, from July 14 to 18, 2019.

From Eisai 19 Jul 2019

How genetic differences in Epstein-Barr virus strains alter the way it behaves

Researchers at the University of Sussex have identified how differences in the genetic sequence of the two main strains of the cancer-associated Epstein-Barr virus can alter the way the virus behaves when it infects white blood cells.

19 Jul 2019

Dermal tattoo biosensors for detecting metabolites and blood pH change

The art of tattooing may have found a diagnostic twist. A team of scientists in Germany have developed permanent dermal sensors that can be applied as artistic tattoos.

18 Jul 2019

Climate change and increasing CO2 could decrease the availability of critical nutrients

One of the biggest challenges to reducing hunger and undernutrition around the world is to produce foods that provide not only enough calories but also make enough necessary nutrients widely available.

18 Jul 2019

Research team detects novel mechanism of inheritance

Non-Mendelian, oligogenic inheritance could bean unrecognized and important element for occurrence ofhereditary retinal degenerations (HRDs, comprising retinitis pigmentosa) which are caused by ultra-rare mutations and cause progressive blindness.

18 Jul 2019

Researchers explain why fascioliasis patients have increased risk for neurological diseases

Fascioliasis is a parasitic disease caused by two species that are present in the liver: Hepatic Fasciola, which is present worldwide, and Fasciola gigantica, which is in Asia and Africa.

18 Jul 2019

Light at last: why do more women develop Alzheimer’s disease?

Alzheimer’s disease (AD) is a leading cause of dementia in many older people, but it seems to affect twice as many women as men. Scientists have long tried to find out why this is so, and why it seems to follow a fast-track course in women.

18 Jul 2019

Human genotype determines if a given Alzheimer's drug will be effective

University at Buffalo researchers have determined that a human gene present in 75 % of the population is a key reason why a class of drugs for Alzheimer's disease seemed promising in animal studies only to fail in human studies.

18 Jul 2019

Oxidative stress could play key role in the spreading of aberrant proteins in Parkinson's disease

Oxidative stress could be a driving force in the spreading of aberrant proteins involved in Parkinson's disease.

17 Jul 2019

Scientists discover how resistance to the chemotherapy drug 5-fluorouracil arises

Australian researchers have unlocked the mystery as to why the chemotherapy drug 5-Fluorouracil is not effective at treating certain cancers.

17 Jul 2019

Molecular switches may control lifespan and healthspan separately, genetic discovery suggests

Aging research indicates that better healthspan--the quality of life as we age--may be more important than lifespan.

17 Jul 2019

UNLV nutritionist explains how putting a halt on sweet treats affects the body

From birthday cakes to Thanksgiving pie to cold summer treats, every holiday, season or special occasion harkens mouth-watering memories of a favorite sugary treat.

17 Jul 2019

Women's greater immune response to flu vaccine declines with age

Women tend to have a greater immune response to a flu vaccination compared to men, but their advantage largely disappears as they age and their estrogen levels decline, suggests a study from researchers at the Johns Hopkins Bloomberg School of Public Health.

17 Jul 2019

Rutgers researchers create new device to see if targeted cancer therapy is working

Rutgers researchers have created a device that can determine whether targeted chemotherapy drugs are working on individual cancer patients.

17 Jul 2019

Researchers identify chemical compounds that increase stability of haploid cell

Since the emergence of molecular genetics more than fifty years ago, scientists have tried to isolate haploid mammalian cells, that is, cells with half the number of chromosomes contained in somatic cells. Haploid cells are a powerful genetic tool to analyze gene function.

17 Jul 2019

Research on increasing insulin’s shelf life may have significant implications for health care

Insulin, a medication used to treat diabetes, is temperature-sensitive and has a short shelf life. It can be stored unopened for up to a year, but once opened, it must be used within weeks or even days.

17 Jul 2019

Gene modulation goes wireless hacking the "boss gene"

Researchers from the University at Buffalo have successfully used technology to wirelessly tweak the functioning of a gene FGFR1. This gene is vital in the growth of embryos into adults. Their experiments were successful in the lab grown brain tissues and shows potential in therapeutics.

16 Jul 2019

Study finds sex-specific differences in risk and progression of Alzheimer's disease

The abnormal accumulation of proteins in the brain is a biological marker for Alzheimer's disease, but the ways in which these proteins spread may help explain why the prevalence of Alzheimer's is higher in women than in men.

16 Jul 2019

Researchers find mechanism behind susceptibility to viral infections

A team of researchers from the SingHealth Duke-NUS Academic Medicine Centre's Viral Research and Experimental Medicine Centre found that immune cells undergoing stress and an altered metabolism are the reasons why some individuals become sick from viral infections while others do not, when exposed to the same virus.

16 Jul 2019

Inhibition of p38 protein boosts formation of blood vessels in colon cancer

A study performed at the Institute for Research in Biomedicine and published in the journal Nature Communications demonstrates that inhibition of the p38 protein boosts the formation of blood vessels in human and mice colon cancers.

16 Jul 2019

Protein C News and Research

Eisai presents new research evaluating correlation of Abeta in plasma and CSF with automated protein assay system

How genetic differences in Epstein-Barr virus strains alter the way it behaves

Dermal tattoo biosensors for detecting metabolites and blood pH change

Climate change and increasing CO2 could decrease the availability of critical nutrients

Research team detects novel mechanism of inheritance

Researchers explain why fascioliasis patients have increased risk for neurological diseases

Light at last: why do more women develop Alzheimer’s disease?

Human genotype determines if a given Alzheimer's drug will be effective

Oxidative stress could play key role in the spreading of aberrant proteins in Parkinson's disease

Scientists discover how resistance to the chemotherapy drug 5-fluorouracil arises

Molecular switches may control lifespan and healthspan separately, genetic discovery suggests

UNLV nutritionist explains how putting a halt on sweet treats affects the body

Women's greater immune response to flu vaccine declines with age

Rutgers researchers create new device to see if targeted cancer therapy is working

Researchers identify chemical compounds that increase stability of haploid cell

Research on increasing insulin’s shelf life may have significant implications for health care

Gene modulation goes wireless hacking the "boss gene"

Study finds sex-specific differences in risk and progression of Alzheimer's disease

Researchers find mechanism behind susceptibility to viral infections

Inhibition of p38 protein boosts formation of blood vessels in colon cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News